Univ.-Klinik für Radiodiagnostik, Division für Molekulare und Gender-Bildgebung, Medizinische Universität Wien, Währinger Gürtel 18-20, A-1090, Wien, Österreich.
Prostate cancer is biologically and clinically a heterogeneous disease which makes imaging evaluation challenging. Magnetic resonance imaging (MRI) has considerable potential to improve prostate cancer detection and characterization. Until recently morphologic MRI has not been routinely incorporated into clinical care because of its limitation to detect, localize and characterize prostate cancer. Performing prostate gland MRI using functional techniques has the potential to provide unique information regarding tumor behavior, including treatment response. In order for multiparametric MRI data to have an impact on patient management, the collected data need to be relayed to clinicians in a standardized way for image construction, analysis and interpretation. This will ensure that patients are treated effectively and in the most appropriate way. Scoring systems similar to those employed successfully for breast imaging need to be developed.
Article in German.
Written by:
Fueger BJ, Helbich TH, Schernthaner M, Zbýň S, Linhart HG, Stiglbauer A, Doan A, Pinker K, Heinz G, Padhani AR, Brader P. Are you the author?
Reference: Radiologe. 2011 Oct 7. Epub ahead of print.
doi: 10.1007/s00117-011-2179-x
PubMed Abstract
PMID: 21976041
UroToday.com Prostate Cancer Section
